CN Stock MarketDetailed Quotes

600211 Tibet Rhodiola Pharmaceutical Holding

Watchlist
  • 35.83
  • +0.53+1.50%
Not Open Aug 16 15:00 CST
11.55BMarket Cap13.95P/E (TTM)

Tibet Rhodiola Pharmaceutical Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tibet Rhodiola Pharmaceutical Holding Q2 2024 Earnings Date

Currency：CNYAug 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
517.98M
--
+109.04%
EPS
--
1.93
--
-19.58%
Analyst Rating
Strong Buy

Aug 18, 2024

Tibet Rhodiola Pharmaceutical Holding Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.070B--
--2024/FY-- / 3.438B--
Mar 27, 20242023/FY3.134B / 3.506B--
Mar 13, 20202019/FY1.256B / 1.380B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.070B--
--2024/FY-- / 3.438B--
Mar 27, 20242023/FY3.134B / 3.506B--
Mar 13, 20202019/FY1.256B / 1.380B--
--------

Unlock Free Earnings Estimates

Tibet Rhodiola Pharmaceutical Holding Earnings Reports

  • Tibet Rhodiola Pharmaceutical Holding Semi-annual Report for 2023

    Aug 14 00:00

  • Summary of Tibet Rhodiola Pharmaceutical Holding's H1 2024 report.

    Aug 14 00:00

  • Tibet Pharmaceutical Report for the First Quarter of 2024

    Apr 27 00:00

  • Summary of Tibet Pharmaceutical's 2023 Annual Report

    Mar 27 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 18, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg